Skip to main content

Mutants of Apolipoproteins A and C

  • Conference paper
  • 23 Accesses

Part of the Verhandlungen der Deutschen Gesellschaft für Innere Medizin book series (VDGINNERE,volume 92)

Abstract

The determination of the circulating levels of apolipoproteins has become common practice in clinical laboratories, in view of the apparent correlation between levels of specific apolipoproteins and increased or decreased cardiovascular risk [1, 2]. In particular, increased apolipoprotein B levels, both in whole plasma and in specific lipoprotein fractions, e.g. low density lipoproteins (LDL) [3], seem to be associated to a raised risk, the opposite being the case for apo AI [4]. Increased apolipoprotein (apo) E levels have been described in primary dysbetalipoproteinemia, often associated with premature vascular diseases [5]; on the other hand, the reductions of both apo AI and, as more recently described, apo D levels [6], seem to be correlated with a raised cardiovascular risk. Similar correlations for other apolipoproteins, although evaluated by numerous Authors, have not provided univocal findings in terms of predictivity of risk.

Key Words

  • Lipoproteins
  • Mutants
  • Atherosclerosis
  • Lecithin Cholesterol Acyltrans-ferase
  • Lipoprotein Lipase
  • Molecular Biology

This is a preview of subscription content, access via your institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • DOI: 10.1007/978-3-642-85459-0_75
  • Chapter length: 10 pages
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
eBook
USD   44.99
Price excludes VAT (USA)
  • ISBN: 978-3-642-85459-0
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Avogaro P, Bittolo-Bon G, Cazzolato G, Quinci GB (1979) Are apolipoproteins better discriminators than lipids for atherosclerosis? Lancet i: 901–903

    CrossRef  Google Scholar 

  2. Noma A Yokosuka T, Kitamura K (1983) Plasma lipids and apolipoproteins as discriminators for presence and severity of angiographically defined coronary artery disease. Atherosclerosis 49:1–7-3.

    PubMed  CrossRef  CAS  Google Scholar 

  3. Sniderman AD, Wolfson C, Teng B, Franklin FA, Bachorik PS, Kwiterovich PO (1982) Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and atherosclerosis. Ann Intern Med 97:833–839

    PubMed  CrossRef  CAS  Google Scholar 

  4. Kukita M, Hiwada K, Kokubu T (1984) Serum apolipoprotein A-I, A-II and B levels and their discriminative values in relatives of patients with coronary artery disease. Atherosclerosis 51:261–267

    PubMed  CrossRef  CAS  Google Scholar 

  5. Havel RJ, Kane P. (1973) Primary dysbetalipoproteinemia, predominance of a specific apoprotein species in triglyceride-rich lipoproteins. Proc Natl Acad Sci USA 70:2015–2018

    PubMed  CrossRef  CAS  Google Scholar 

  6. James RW, Martin B, Pometta D, Grab B, Suenram A (1985) Apoprotein D in a healthy, male population and in male myocardial infarction patients and their male, first-degree relatives. Atherosclerosis 60:49–53

    CrossRef  Google Scholar 

  7. Breslow JL (1984) Molecular genetics of lipoprotein disorders. Circulation 69:1190–1194

    PubMed  CrossRef  CAS  Google Scholar 

  8. Zannis VI, Breslow JL (1982) Apolipoprotein E. Mol Cell Biochem 42:3–20

    PubMed  CrossRef  CAS  Google Scholar 

  9. Franceschini G, Sirtori CR, Capurso A, Weisgraber KM, Mahley RW (1980) Al-Milano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family. J Clin Invest 66:892–900

    PubMed  CrossRef  CAS  Google Scholar 

  10. Swaney JB, Braithwaite F, Eder HA (1977) Characterization of the apolipoproteins of rat plasma lipoproteins. Biochemistry 16:271–278

    PubMed  CrossRef  CAS  Google Scholar 

  11. Fidge NH (1980) The redistribution and metabolism of iodinated apolipoprotein AIV in rats. Biochim Biophys Acta 619:129–141

    PubMed  CrossRef  CAS  Google Scholar 

  12. Swift LL, Soulé PD, Gray ME, Le Quire VS: Intestinal lipoprotein synthesis. Comparison of nascent Golgi lipoproteins from chow-fed and hypercholesterolemic rats. J Lipid Res 25:1–13

    Google Scholar 

  13. Weinberg RB, Spector MS (1985) Structural properties and lipid binding of human apolipoprotein AIV. J Biol Chem 260:4914–4921

    PubMed  CAS  Google Scholar 

  14. Chen CH, Albers JJ (1985) Activation of lecithin:cholesterol acyltransferase by apolipoproteins E-2, E-3, and AIV isolated from human plasma. Biochim Biophys Acta 836:279–285

    PubMed  CrossRef  CAS  Google Scholar 

  15. Karathanasis SK (1985) Apolipoprotein multigene family: tandem organisation of human apolipoprotein AI, CIII, and AIV genes Proc Natl Acad Sci USA 82:6374–6378

    CrossRef  CAS  Google Scholar 

  16. Brewer HB, Fairwell T, La Rue A, Rorian R, Hauser A, Bronzert TJ (1978) The amino acid sequence of human apo AI, an apolipoprotein isolated from high density lipoproteins. Biochim Biophys Res Comm 80:623–629

    CrossRef  CAS  Google Scholar 

  17. Zannis VI, Karathanasis SK, Kentmann HT, Goldberg G, Breslow JL (1983) Intracellular and extracellular processing of human apolipoprotein AI: secreted apolipoprotein AI isoprotein 2 is a propeptide. Proc Natl Acad Sci USA 80:2574–2578

    PubMed  CrossRef  CAS  Google Scholar 

  18. Oram JF (1983) Effects of high density lipoprotein subfractions on cholesterol homeostasis in human fibroblasts and arterial smooth muscle cells. Arteriosclerosis 3:420–432

    PubMed  CrossRef  CAS  Google Scholar 

  19. Weisgraber KH, Mahley RW (1978) Apoprotein (E-AII) complex of human plasma lipoproteins. I. Characterization of this mixed disulfide and its identification in a high density lipoprotein subfraction. J Biol Chem 253:6281–6288

    PubMed  CAS  Google Scholar 

  20. Schamaun O, Olaisen B, Gedde-Dahl T jr, Teisberg P (1983) Genetic studies of an apo AI lipoprotein variant. Hum Genet 64:380–383 -

    PubMed  CrossRef  CAS  Google Scholar 

  21. Weisgraber KH, Bersot TP, Mahley RW, Franceschini G, Sirtori CR (1980) AI-Milano apoprotein. Isolation and characterization of a cysteine-containing variant of the AI apoprotein from human high density lipoproteins. J Clin Invest 66:901–907

    PubMed  CrossRef  CAS  Google Scholar 

  22. Weisgraber KH, Rall SC Jr, Bersot TP, Mahley RW, Fraceschini G, Sirtori CR (1983) Apolipoprotein AI-Milano: Detection of normal AI in affected subjects and evidence for a cysteine for arginine substitution in the variant AI. J Biol Chem 258:2508–2513

    PubMed  CAS  Google Scholar 

  23. Gualandri V, Franceschini G, Sirtori CR, Gianfranceschi G, Orsini GB, Cerrone A, Menotti A, (1985) AI Milano apoprotein. Identification of the complete kindred and evidence of a dominant genetic transmission. Am J Hum Genet 37:1083–1097

    PubMed  CAS  Google Scholar 

  24. Franceschini G, Frosi TG, Manzoni C, Gianfraceschi G, Sirtori CR (1982) High density lipoproteins heterogeneity in subjects with the apo AI-Milano variant. J Biol Chem 257:9926–9930 -

    PubMed  CAS  Google Scholar 

  25. Franceschini G, Vecchio G, Gianfraceschi G, Magani G, Sirtori CR, (1985) Apolipoprotein AI Milano. Accelerated binding and dissociation from lipids of a human apolipoprotein variant. J Biol Chem 260:16321–16325

    PubMed  CAS  Google Scholar 

  26. Rall SC Jr, Weisgraber KH, Mahley RW, Ogawa Y, Fielding CJ, Utermann G, Haas J, Steinmetz A, Menzel HJ, Assmann G (1984) Abnormal lecithin: cholesterol acyltransferase activation by a human apolipoprotein AI variant in which a single lysine residue is deleted. J Biol Chem 259:10063–10070

    PubMed  CAS  Google Scholar 

  27. Utermann G, Haas J, Steinmetz A, Paetzold SC, Rall SC jr, Weisgraber KH, Mahley RW (1984) Apolipoprotein AL-Gießen: apo A-I (Pro143 → Arg). A mutant that is defective in activating lecithin: cholesterol acyltransferase. Eur J Biochem 144:325–331

    CAS  Google Scholar 

  28. Norum RA, Lakier JB, Goldstein S, Angel A, Goldberg RB, Block WD Noffze DK, Dolphin PJ, Edelglass J, Bogorad DD, Alaupovic P (1982) Familial deficiency of apolipoproteins AI and C III and precocious coronary-artery disease. N Engl J Med 306:1513–1519

    PubMed  CrossRef  CAS  Google Scholar 

  29. Schaefer EJ, Heaton WH, Wetzel MG, Brewer HB jr (1982) Plasma apolipoprotein AI absence associated with a marked reduction of high density lipoproteins and premature coronary artery disease. Arteriosclerosis 2:16–26

    PubMed  CrossRef  CAS  Google Scholar 

  30. Karathanasis SK, Norum RA, Zannis VI, Breslow JL (1983) An inherited polymorphism in the human apolipoprotein AI gene locus related to the development of atherosclerosis. Nature 301:718–720

    PubMed  CrossRef  CAS  Google Scholar 

  31. Schaefer EJ, Ordovas JM, Law SW, Ghiselli GC, Kashyap MT, Srivastava LS, Heaton WH, Albers JJ, Connor WE, Lindgren FT, Lemeshev Y, Segrest JP, Brewer HB jr (1985) Familial apolipoprotein AI and CIII deficiency, variant II. J Lipid Res 26:1089–1101

    PubMed  CAS  Google Scholar 

  32. Fredrickson DS (1965) The inheritance of high density lipoprotein deficiency (Tangier disease). J Clin Invest 44:228–237

    Google Scholar 

  33. Carlson LA (1982) Fish eye disease: a new familial condition with massive corneal opacities and dyslipoproteinemia. Eur J Clin Invest 12:41–53

    PubMed  CrossRef  CAS  Google Scholar 

  34. Schaefer EJ, Kay LL, Zech LA, Brewer HB jr (1982) Tangier disease: high density lipoprotein deficiency due to defective metabolism of an abnormal apolipoprotein A-I (Apo A-ITangier). J Clin Invest 70:934–945

    PubMed  CrossRef  CAS  Google Scholar 

  35. Rees A, Stocks J, Shoulders C, Carlson LA, Baralle FE, Galton DJ (1984) Restriction enzyme analysis of the apolipoprotein AI gene in Fish Eye Disease and Tangier Disease. Acta Med Scand 215:235–237

    PubMed  CrossRef  CAS  Google Scholar 

  36. Law SW, Brewer HB jr (1985) Tangier Disease: The complete mRNA sequence encoding for preproapo-A-I. J Biol Chem 260:12810–12814

    PubMed  CAS  Google Scholar 

  37. Schmitz G, Assmann G, Robenek H, Brennhausen B (1985) Tangier disease: a disorder of intracellular membrane traffic. Proc Natl Acad Sci USA 82:6305–6309

    PubMed  CrossRef  CAS  Google Scholar 

  38. Carlson LA, Holmquist L (1985) Evidence for deficiency of high density lipoprotein lecithin: cholesterol acyltransferase activity (α-LCAT) in Fish Eye disease. Acta Med Scand 218:189–196

    PubMed  CrossRef  CAS  Google Scholar 

  39. Kinnunen PKJ, Jackson RL, Smith LC, Gotto AM jr, Sparrow JT (1977) Activation of lipoprotein lipase by native and synthetic fragments of human plasma apolipoprotein CIL Proc Natl Acad Sci USA 74:4848–4851

    CrossRef  CAS  Google Scholar 

  40. Lukens TW, Borensztajn J (1978) Effects of C apoproteins on the activity of endothelium-bound lipoprotein lipase. Biochem J 175:1143–1146

    PubMed  CAS  Google Scholar 

  41. Windier E, Chao YS, Havel RJ (1980) Determinants of hepatic uptake of triglyceride-rich lipoproteins and their remnants in the rat. J Biol Chem 255:5475–5480

    Google Scholar 

  42. Shelburne FJ, Meyers HW, Quarfordt S (1980) Effect of apoproteins on hepatic uptake of triglyceride emulsions in the rat. J Clin Invest 65:652–658

    PubMed  CrossRef  CAS  Google Scholar 

  43. Soutar AK, Sigler GF, Smith LC, Gotto AM jr, Sparrow JT (1978) Lecithin: cholesterol acyltransferase activation and lipid binding by synthetic fragments of apolipoprotein CI. Scand J Clin Lab Invest 38 (Suppl 150): 53–38

    CrossRef  CAS  Google Scholar 

  44. Humphries SE, Berg K, Gill L, Cumming AM, Robertson FW, Stalenhoef AFH, Williamson R, Borresen AL (1984) The gene for apolipoprotein C-II is closely linked to the gene for apolipoprotein E on chromosome 19. Clin Genet 26:389–396 -

    PubMed  CrossRef  CAS  Google Scholar 

  45. Myklebost O, Rogne S, Loasen B, Gedde-Dahl T jr, Prydz H (1984) The locus for apolipoprotein C-II is closely linked to the apolipoprotein E locus on chromosome 19 in man. Hum Genet 67:309–312

    PubMed  CrossRef  CAS  Google Scholar 

  46. Breckenridge WC, Little JA, Steiner G, Chow A, Poast M (1978) Hypertriglyceridemia associated with deficiency of apolipoprotein CII. N Engl J Med 298:1265–1273

    PubMed  CrossRef  CAS  Google Scholar 

  47. Breckenridge WC, Cox D, Little JA (1978) Inheritance of apolipoprotein C-II deficiency with hypertriglyceridemia and pancreatitis. N Engl J Med 299:1421–1424

    PubMed  CrossRef  Google Scholar 

  48. Yamamura T, Sudo H, Ishikawa K, Yamamoto A (1979) Familial type I hyperlipoproteinemia caused by apolipoprotein CII deficiency. Atherosclerosis 34:53–65

    PubMed  CrossRef  CAS  Google Scholar 

  49. Miller NE, Rao SN, Alaupovic L, Noble N, Slack Y, Brunzell Y D, Lewis B (1981) Familial apolipoprotein CII deficiency: plasma lipoproteins and apolipoproteins in heterozygous and homozygous subjects and the effects of plasma infusion. Eur J Clin Invest 11:69–76

    PubMed  CrossRef  CAS  Google Scholar 

  50. Baggio G, Manzato E, Gabelli C, Fellin R, Martini S, Baldo Enzi G, Verlato F, Baiocchi MR, Sprecher DL, Kashyap ML, Brewer HB jr, Crepaldi G (1986) Apolipoprotein CII deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients J Clin Invest 77:520–527

    CAS  Google Scholar 

  51. Cox DW, Breckenridge WC, Little JA (1978) Inheritance of apolipoprotein CII deficiency with hypertriglyceridemia and pancreatitis. N Engl J Med 299:1421–1424

    PubMed  CrossRef  CAS  Google Scholar 

  52. Maguire GH, Little JA, Kakis G, Breckenridge WC (1984) Apolipoprotein C-II deficiency associated with nonfunctional mutant forms of apolipoprotein C-II. Can J Biochem 62:847–852

    CrossRef  CAS  Google Scholar 

  53. Crepaldi G, Fellin R, Baggio G, Augustin J, Greten H (1980) Lipoprotein and apoprotein, adipose tissue and hepatic lipoprotein lipase levels in patients with hyperchylomicronemia and their immediate family members. In: Gotto AM jr, Smith LC, Allen B (eds) Atherosclerosis V. Springer, New York, pp 250–254

    CrossRef  Google Scholar 

  54. Sprecher DL, Taam L, Brewer HB jr (1984) Two dimensional electrophoresis of human plasma apolipoproteins. Clin Chem 30:2084–2092

    PubMed  CAS  Google Scholar 

  55. Menzel HJ, Kane JP, Malloy HJ, Havel RJ (1986) A variant primary structure of apolipoprotein CII in individuals of African descent J Clin Invest 77:595–601

    PubMed  CrossRef  CAS  Google Scholar 

  56. Havel RJ, Kotite L, Kane JP (1979) Isoelectric heterogeneity of the cofactor protein for lipoprotein lipase in human blood plasma. Biochem Med 21:121–128

    PubMed  CrossRef  CAS  Google Scholar 

  57. Mahley RW, Innerarity TL, Rall SC jr, Weisgraber KH (1984) Plasma lipoproteins: apolipoprotein structure and function. J Lipid Res 25:1277–1294

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and Permissions

Copyright information

© 1986 J. F. Bergmann Verlag, München

About this paper

Cite this paper

Sirtori, C.R., Lovati, M.R. (1986). Mutants of Apolipoproteins A and C. In: Miehlke, K. (eds) Verhandlungen der Deutschen Gesellschaft für Innere Medizin. Verhandlungen der Deutschen Gesellschaft für Innere Medizin, vol 92. J.F. Bergmann-Verlag, Munich. https://doi.org/10.1007/978-3-642-85459-0_75

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-85459-0_75

  • Publisher Name: J.F. Bergmann-Verlag, Munich

  • Print ISBN: 978-3-8070-0360-3

  • Online ISBN: 978-3-642-85459-0

  • eBook Packages: Springer Book Archive